Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack

European Journal of Medicinal Chemistry

Volumn 103, Issue , 2015, Pages 133-162

  Ghani, Usman ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anti diabetic drugs; Drug development; Natural; Synthetic; glucosidase inhibitors

Indexed keywords

ACARBOSE; ALKALOID DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; AMINOCYCLITOL; AMINOSUGAR; ANTHRAQUINONE DERIVATIVE; CHALCONE DERIVATIVE; CURCUMIN; CYCLITOL; FLAVONOID; IMINOSUGAR; MACROLIDE; MIGLITOL; ORAL ANTIDIABETIC AGENT; PEPTIDE DERIVATIVE; STEROID; STILBENE DERIVATIVE; TERPENE DERIVATIVE; TERPHENYL DERIVATIVE; THIADIAZOLE DERIVATIVE; THIOSUGAR; UREA DERIVATIVE; VOGLIBOSE; XANTHONE DERIVATIVE; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; GLYCOSIDASE INHIBITOR;

ANTIDIABETIC ACTIVITY; DIABETES MELLITUS; DRUG EFFICACY; HUMAN; IC50; NONHUMAN; PHARMACOPHORE; REVIEW; STRUCTURE ACTIVITY RELATION; CHEMISTRY; ENZYMOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ALPHA-GLUCOSIDASES; DIABETES MELLITUS; GLYCOSIDE HYDROLASE INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84941131320     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2015.08.043     Document Type: Review

References (181)

1. H.G. Eichler, A. Korn, S. Gasic, W. Prison, J. Businger, The effect of a new specific alpha-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and type 2 (non-insulin-dependent) diabetic patients, Diabetologia 26 (1984) 278-281.
2. D.V. Nguyen, L.C. Shawand, M.B. Grant, Inflammation in the pathogenesis of microvascular complications in diabetes, Front. Endocrinol. (Lausanne) 3 (2012) 1-7.
3. S. Wild, G. Roglic, A. Green, R. Sicree, H. King, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care 27 (2004) 1047-1053.
4. M.M. Al-Nozha, M.A. Al-Maatouq, Y.Y. Al-Mazrou, et al., Diabetes mellitus in Saudi Arabia, Saudi Med. J. 25 (2004) 1603-1610.
5. A. Alzaid, Diabetes: a tale of two cultures, Br. J. Diabetes Vas. Dis. 12 (2012) 57-59.
6. R.A. Bacchus, J.L. Bell, M. Madkour, B. Kilshaw, The prevalence of diabetes mellitus in male Saudi Arabs, Diabetologia 23 (1982) 330-332.
7. H.H. Fatani, S.A. Mira, A.G. El-Zubier, Prevalence of diabetes mellitus in rural Saudi Arabia, Diabetes Care 10 (1987) 180-183.
8. H.A. Abu-Zeid, A.S. Al-Kassab, Prevalence and health-care features of hyperglycemia in semiurban-rural communities in southern Saudi Arabia, Diabetes Care 15 (1992) 484-489.
9. M.A. El-Hazmi, A.S. Warsy, A.R. Al-Swailem, et al., Diabetes mellitus and impaired glucose tolerance in Saudi Arabia, Ann. Saudi Med. 16 (1996) 381-385.
10. A.R. Al-Nuaim, Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia, Diabet. Med. 14 (1997) 595-602.
11. American Diabetes Association, USA. http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html (accessed August 2015).
12. B.T. Srinivasan, J. Jarvis, K. Khunti, M.J. Davies, Recent advances in the management of type 2 diabetes mellitus: a review, Postgrad. Med. J. 84 (2008) 524-531.
13. K.C. Maki, M.L. Carson, M.P. Miller, M. Turowski, M. Bell, D.M. Wilder, M.S. Reeves, High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses, Diabetes Care 30 (2007) 1039-1043.
14. H.A. Ernst, et al., Structure of the Sulfolobus solfataricus α-Glucosidase: implications for domain conservation and substrate recognition in GH3, J. Mol. Biol. 358 (2006) 1106-1124.
15. B. Henrissat, A classification of glycosyl hydrolases based on amino-acid sequence similarities, Biochem. J. 280 (1991) 309-316.
16. B. Henrissat, A. Bairoch, New families in the classification of glycosyl hydrolases based on aminoacid sequence similarities, Biochem. J. 293 (1993) 781-788.
17. A.J. Krentz, C.J. Bailey, Oral antidiabetic agents: current role in type 2 diabetes mellitus, Drugs 65 (2005) (2005) 385-411.
18. D.O. Schmidt, W. Frommer, L. Muller, E. Truscheit, Glucosidase inhibitors from bacilli, Natunlinenschafien 66 (1979) 584-585.
19. W. Puts, U. Keup, I.J.P. Krause, G. Thomas, F. HoO'meister, Glucosidase inhibition: a new approach to the treatment of diabetes, obesity, and hypcrlipoproteinaemia, Naturwissenschafien 64 (1977) 536-537.
20. N. Asano, Naturally occurring iminosugars and related compounds: structure, distribution, and biological activity, Curr. Top. Med. Chem. 3 (2003) 471-484.
21. Y. Kameda, N. Asano, M. Yoshikawa, M. Takeuchi, T. Yamaguchi, K. Matsui, S. Horii, H. Fukase, Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by streptomyces hygroscopicus, J. Antibiot. 37 (1984) 1301-1307.
22. S. Horii, H. Fukase, T. Matsuo, Y. Kameda, N. Asano, K. Matsui, Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents, J. Med. Chem. 29 (1986) 1038-1046.
23. R. Kawamori, N. Tajima, Y. Iwamoto, A. Kashiwagi, K. Shimamoto, K. Kaku, Voglibose Ph-3 study group. Voglibose for prevention of type 2 diabetes mellitus: a randomised, doubleblind trial in Japanese individuals with impaired glucose tolerance, Lancet 373 (2009) 1607-1614.
24. A. Vichayanrat, S. Ploybutr, M. Tunlakit, P. Watanakejorn, Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients, Diabetes Res. Clin. Pract. 55 (2002) 99-103.
25. S. Inoue, T. Tsuruoka, T. Niida, The structure of nojirimycin, a piperidinose sugar antibiotic, Antibiot. 19 (1966) 288-292.
26. T. Niwa, T. Tsuruoka, H. Goi, Y. Kodama, J. ltoh, S. lnoue, Y. Yamada, T. Niida, M. Nobe, Y. Ogawa, Novel glycosidase inhibitors, nojirimycin B and Dmannonic δ- lactam. Isolation, structure determination and biological property, J. Antibiot. 37 (1984) 1579-1586.
27. T. Niwa, S. Inoue, T. Tsuruoka, Y. Koaze, T. Niida, Nojirimycin as a potent inhibitor of glucosidase, Agric. Biol. Chem. 34 (1970) 966-968.
28. Y. Kodama, T. Tsuruoka, T. Niwa, S. Inoue, Molecular structure and glycosidase-inhibitory activity of nojirimycin bisulfite adduct, J. Antibiot. 38 (1985) 116-118.
29. G. Legler, S. Pohl, Synthesis of 5-amino-5-deoxy-D-galactopyranose and I,5-dideoxy-1,5-imino-D-galactitol, and their inhibition of α- and β-galactosidases, Carbohydr. Res. 155 (1986) 119-129.
30. Y. Miyake, M. Ebata, Inhibition of a-galactosidase by galactostatin, galactostatin-lactam and 1-deoxygalactostatin, Agric. Biol. Chem. 52 (1988) 1649-1654.
31. M. Yagi, T. Kouno, Y. Aoyagi, H. Murai, The structure of moraoline, a piperidine alkaloid from Morus species, Nippon. Nougei Kagaku Kaishi 50 (1976) 571-572 (in Japanese).
32. B. Junge, M. Matzke, J. Stohefuss, Chemistry and structure-activity relationships of glucosidase inhibitors, in: J. Kuhlmann, W. Puis (Eds.), Handbook of Experimental Pharmacology, vol. 119, Springer-Verlag, Berlin, Heidelberg, New York, 1996, pp. 411-482.
33. P.H. Joubert, G.N. Foukaridis, M.L. Bopape, Miglitol may have a blood glucose lowering effect unrelated to inhibition of α-glucosidase, Eur. J. Clin. Pharmacol. 31 (1987) 123.
34. P.H. Joubert, H.L. Venter, G.N. Foukaridis, The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism? Br. J. Clin. Pharmacol. 30 (1990) 391-396.
35. J.P.J.E. Sels, J.J.P. Nauta, P.P.C.A. Menheere, B.H.R. Wolfenbuttel, A.C. Nieuwenhuijzen Kruseman, Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers, Br. J. Clin. Pharmacol. 42 (1996) 503-506.
36. J.L. Chiasson, et al., Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial, Lancet 359 (2002) 2072-2077.
37. J.A. Balfour, D. McTavish, Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus, Drugs 46 (1993) 1025-1054.
38. F.A. van de Laar, P.L. Lucassen, R.P. Akkermans, E.H. van de Lisdonk, G.E. Rutten, C. van Weel, Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a cochrane systematic review and meta-analysis, Diabetes Care 28 (2005) 154-163
39. F.A. van de Laar, P.L. Lucassen, R.P. Akkermans, E.H. van de Lisdonk, G.E. Rutten, C. van Weel, Alpha-glucosidase inhibitors for type 2 diabetes mellitus, Art. No.: CD003639, Cochrane Database Syst. Rev. (2) (2005), http://dx.doi.org/10.1002/14651858. CD003639.pub2.
40. N. Asano, R.J. Nash, R.J. Molyneux, G.W.J. Fleet, Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application, Tetrahedron Asymmetry 11 (2000) (2000) 1645-1680.
41. N. Asano, Glycosidase inhibitors: update and perspectives on practical use, Glycobiology 13 (2003) 93R-104R.
42. T.D. Butters, R.A. Dwek, F.M. Platt, Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses, Glycobiology 15 (2005) 43R-52R.
43. N. Asano, Sugar-mimicking glycosidase inhibitors: bioactivity and application, Cell. Mol. Life Sci. 66 (2009) 1479-1492.
44. A. Trapero, A. Llebaria, A prospect for pyrrolidine iminosugars as antidiabetic α-glucosidase inhibitors, J. Med. Chem. 55 (2012) 10345-10346.
45. K. Suzuki, T. Nakahara, O. Kanie, 3,4-Dihydroxypyrrolidine as glycosidase inhibitor, Curr. Top. Med. Chem. 9 (2009) 34-57.
46. R.J. Nash, A. Kato, C.Y. Yu, G.W. Fleet, Iminosugars as therapeutic agents: recent advances and promising trends, Future Med. Chem. 3 (2011) 1513-1521.
47. N.F. Brás, N.M. Cerqueira, M.J. Ramos, P.A. Fernandes, Glycosidase inhibitors: a patent review (2008-2013), Expert Opin. Ther. Pat. 24 (2014) 857-874.
48. Y. Kobayashi, Carbasugars: synthesis and functions, in: B. Fraser-Reid, K. Tatsuta, J. Thiem (Eds.), Glycoscience, Springer, Verlag Berlin Heidelberg, 2008, pp. 1914-1997. Chapter-DOI 10-1007/978-3-540-30429-6-49.
49. D.J. Wardrop, S.L. Waidyarachchi, Synthesis and biological activity of naturally occurring α-glucosidase inhibitors, Nat. Prod. Rep. 27 (2010) 1431-1468.
50. N. Asano, M. Nishida, M. Miyauchi, K. Ikeda, M. Yamamoto, H. Kizu, Y. Kameda, A.A. Watson, R.J. Nash, G.W.J. Fleet, Polyhydroxylated pyrrolidine and piperidine alkaloids from adenophora triphylla var. japonica (Campanulaceae), Phytochemistry 53 (2000) 379-382.
51. R.J. Nash, E.A. Bell, J.M. Williams, 2-Hydroxymethyl-3,4-dihydroxypyrrolidine in fruits of Angylocalyx boutiqueanus, Phytochemistry 24 (1985) 1620-1622.
52. A. Welter, J. Jadot, G. Dardenne, M. Marlier, J. Casimir, 2,5-Dihydroxymethyl-3,4-dihydroxypyrrolidine dans les feuilles de Derris elliptica, Phytochemistry 15 (1976) 747-749.
53. A.A. Watson, R.J. Nash, M.R. Wonnald, D.J. Harvey, S. Dealler, E. Lees, N. Asano, H. Kizu, A. Kato, R.C. Griffiths, A.J. Cairns, G.W.J. Fleet, Glycosidase inhibiting pyrrolidine alkaloids from Hyacinthoides non-scripta, Phytochemistry 46 (1991) 255.
54. A. Kato, N. Kato, S. Miyauchi, Y. Minoshima, I. Adachi, K. Ikeda, N. Asano, A.A. Watson, R.J. Nash, Iminosugars from Baphia nitida Lodd, Phytochemistry 69 (2008) 1261-1265.
55. G.C. Kite, Linda E. Fellows, George W.J. Fleet, Paul S. Liu, Anthony M. Scofield, Neal G. Smith, α-Homonojirimycin [2,6-dideoxy-2,6-imino-d-glycero-l-guloheptitol] from omphalea diandra L.: isolation and glucosidase inhibition, Tetrahedron Lett. 29 (1988) 6483-6485.
56. N. Asano, M. Nishida, H. Kizu, K. Matsui, A.A. Watson, R.J. Nash, Homonojirimycin isomers and glycosides from Aglaonema treubii, J. Nat. Prod. 60 (1997) 98-101.
57. N. Asano, M. Nishida, A. Kato, H. Kizu, K. Matsui, Y. Shimada, T. Itoh, M. Baba, A.A. Watson, R.J. Nash, P.M. Lilley, D.J. Watkin, G.W.J. Fleet, Homonojirimycin isomers and N-Alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases, J. Med. Chem. 41 (1998) 2565-2571.
58. N. Asano, A. Kato, M. Miyauchi, H. Kizu, Y. Kameda, A.A. Watson, R.J. Nash, G.W.J. Fleet, Nitrogen-containing furanose and pyranose analogues from Hyacinthus orientalis, J. Nat. Prod. 61 (1998) 625-628.
59. O.R. Martin, P. Compain, H. Kizu, N. Asano, Revised structure of a homonojirimycin isomer from Aglaonema treubii: first example of a naturally occurring alpha-homoallonojirimycin, Bioorg. Med. Chem. Lett. 9 (1999) 3171-3174.
60. R.-Y. Yan, H.-Q. Wanga, C. Liu, J. Kang, R.-Y. Chen, α-Glucosidase-inhibitory iminosugars from the leaves of suregada glomerulata, Bioorg. Med. Chem. 21 (2013) 6796-6803.
61. R.J. Nash, P.I. Thomas, R.D. Waigh, G.W.J. Fleet, M.R. Wormald, Q.L. de, M. Paul, D.J. Watkin, Casuarine: a very highly oxygenated pyrrolizidine alkaloid, Tetrahedron Lett. 35 (1994) 7849-7852
62. A. Kato, E. Kano, I. Adachi, R.J. Molyneux, A.A. Watson, R.J. Nash, G.W.J. Fleet, M.R. Wormald, H. Kizu, K. Ikeda, N. Asano, Australine and related alkaloids: easy structural confirmation by 13C NMR spectral data and biological activities, Tetrahedron Asymmetry 14 (2003) 325-331
63. E. Scott, S.E. Denmark, A.R. Hurd, Synthesis of (+)-Casuarine, Org. Lett. 1 (1999) 1311-1314
64. Cardona, C. Parmeggiani, E. Faggi, C. Bonaccini, P. Gratteri, L. Sim, T.M. Gloster, S. Roberts, G.J. Davies, D.R. Rose, A. Goti, Total syntheses of casuarine and its 6-O-α-glucoside: complementary inhibition towards glycoside hydrolases of the GH31 and GH37 families, Chem. Eur. J. 15 (2009) 1627-1636.
65. M. Yoshikawa, T. Murakami, K. Yashiro, H. Matsuda, Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata, Chem. Pharm. Bull. (Tokyo) 46 (1998) 1339-1340.
66. M. Yoshikawa, T. Murakamia, H. Shimadaa, H. Matsudaa, Y. Yamaharab, G. Tanabec, O. Muraokac, Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the ayurvedic traditional medicine salacia reticulata in Sri Lanka and India, Tetrahedron Lett. 38 (48) (1997) 8367-8370.
67. T. Morikawa, J. Akaki, K. Ninomiya, E. Kinouchi, G. Tanabe, Y. Pongpiriyadacha, M. Yoshikawa, O. Muraoka, Salacinol and related analogs: new leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis, Nutrients 7 (2015) 1480-1493.
68. R. Nasi, B.O. Patrick, L. Sim, D.R. Rose, B.M. Pinto, Studies directed toward the stereochemical structure determination of the naturally occurring glucosidase inhibitor, kotalanol: synthesis and inhibitory activities against human maltase glucoamylase of seven-carbon, chain-extended homologues of salacinol, J. Org. Chem. 73 (2008) 6172-6181.
69. L. Sim, K. Jayakanthan, S. Mohan, R. Nasi, B.D. Johnston, B.M. Pinto, D.R. Rose, New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltaseglucoamylase with compounds from Salacia reticulata, Biochemistry 49 (2010) 443-451.
70. T. Tanaka, R. Uehara, K. Nishida, I. Kouno, Galloyl, caffeoyl and hexahydroxydiphenoyl esters of dihydrochalcone glucosides from Balanophora tobiracola, Phytochemistry 66 (2005) 675-681.
71. H.W. Ryu, B.W. Lee, L.J. Curtis-Long, S. Jung, Y.B. Ryu, W.S. Lee, K.H. Park, Polyphenols from Broussonetia papyrifera displaying potent α-glucosidase inhibition, J. Agric. Food Chem. 58 (2010) 202-208.
72. T.K. Tabopda, J. Ngoupayo, P.K. Awoussong, A. Mitaine-Offer, M.S. Ali, B.T. Ngadjui, M. Lacaille-Dubois, Triprenylated flavonoids from Dorstenia psilurus and their α-glucosidase inhibition properties, J. Nat. Prod. 71 (2008) 2068-2072.
73. M. Yoshikawa, H. Shimada, N. Nishida, Y. Li, I. Toguchida, J. Yamahara, H. Matsuda, Antidiabetic principles of natural medicines. II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins I and II and myrciaphenones A and B, Chem. Pharm. Bull. (Tokyo) 46 (1998) 113-119.
74. S. Lee, Hsiao-Ching Lin, Chien-Kuang Chen, Acylated flavonol monorhamnosides, α-glucosidase inhibitors, from Machilus philippinensis, School, Phytochemistry 69 (2008) 2347-2353.
75. T. Matsui, T. Ueda, T. Oki, K. Sugita, N. Terahara, K. Matsumoto, α-Glucosidase inhibitory action of natural acylated anthocyanins. 2. α-glucosidase inhibition by isolated acylated anthocyanins, J. Agric. Food Chem. 49 (2001) 1952-1956.
76. T. Matsui, S. Ebuchi, T. Fujise, K. Abesundara, S. Doi, H. Yamada, K. Matsumoto, Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3, 4, 5-tri-O-caffeoylquinic acid, Biol. Pharm. Bull. 27 (2004) 1797-1803.
77. K. Tadera, Y. Minami, K. Takamatsu, T. Matsuoka, Inhibition of α-glucosidase and α-amylase by flavonoids, J. Nutr. Sci. Vitaminol. 5 (2006) (2006) 149-153.
78. C.W. Choi, Y.H. Choi, M.R. Cha, D.S. Yoo, Y.S. Kim, G.H. Yon, K.S. Hong, Y.H. Kim, S.Y. Ryu, Yeast α-glucosidase inhibition by isoflavones from plants of Leguminosae as an in vitro alternative to acarbose, J. Agric. Food Chem. 58 (2010) 9988-9993.
79. H.J. Yuk, J.H. Lee, M.J. Curtis-Long, J.W. Lee, Y.S. Kim, H.W. Ryu, C.G. Park, T.S. Jeong, K.H. Park, The most abundant polyphenol of soy leaves, coumestrol, displays potent α-glucosidase inhibitory activity, Food Chem. 126 (2011) 1057-1063.
80. W. Hakamata, I. Nakanishi, Y. Masuda, T. Shimizu, H. Higuchi, Y. Nakamura, S. Saito, S. Urano, T. Oku, T. Ozawa, N. Ikota, N. Miyata, H. Okuda, K. Fukuhara, Planar catechin analogues with alkyl side chains:Apotent antioxidant and an α-glucosidase inhibitor, J. Am. Chem. Soc. 128 (2006) 6524-6525.
81. S. Ochir, M. Nishizawa, B.J. Park, K. Ishii, T. Kanazawa, M. Funaki, T. Yamagishi, Inhibitory effects of Rosa gallica on the digestive enzymes, J. Nat. Med. 64 (2010) 275-280.
82. E.J. Seo, Marcus J. Curtis-Long, Byong Won Lee, Hoi Young Kim, Young Bae Ryu, Tae-Sook Jeong, Woo Song Leec, Ki Hun Park, Xanthones from Cudrania Tricuspidata displaying potent α-glucosidase inhibition, Bioorg. Med. Chem. Lett. 17 (2007) 6421-6424.
83. K.H. Park, Y.D. Park, J.M. Han, K.R. Im, B.W. Lee, I.Y. Jeong, T.S. Jeong, W.S. Lee, Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata, Bioorg. Med. Chem. Lett. 16 (2006) 5580-5583.
84. B.W. Lee, J.H. Lee, S.T. Lee, H.S. Lee, W.S. Lee, T.S. Jeong, K.H. Park, Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata, Bioorg. Med. Chem. Lett. 15 (2005) 5548-5552.
85. V. Peres, T.J. Nagem, F.F. Oliveira, Tetraoxygenated naturally occurring xanthones, Phytochemistry 55 (2000) 683-710.
86. H.W. Ryu, J.K. Cho, M.J. Curtis-Long, H.J. Yuk, Y.S. Kim, S. Jung, K.H. Park, α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana, Phytochemistry 72 (2011) 2148-2154.
87. Y.C. Yang, Tibetan Medicine, Qinghai People's Publishing House, Xining, China, 1991, pp. 111-112.
88. P. Basnet, S. Kadota, M. Shimizu, T. Namba, Bellidifolin: a potent hypoglycemic agent in streptozotocin (STZ)-induced diabetic rats from Swertia japonica, Planta Med. 60 (1994) 507-511.
89. H. Zheng, Cui-Ting Luo, Heru Chen, Juan-Na Lin, Chun-Ling Ye, Shuang-Shuang Mao, Yu-Lin Li, Xanthones from Swertia mussotii as multitargetdirected antidiabetic agents, ChemMedChem 9 (2014) 1374-1379.
90. R.J. Marles, N.R. Farnsworth, Antidiabetic plants and their active constituents, Phytomedicine 2 (1995) 137-189.
91. H. Oe, S. Ozaki, Hypoglycemic effect of 13-membered ring thiocyclitol, a novel-glucosidase inhibitor from Kothala-himbutu (Salacia reticulate), Biosci. Biotechnol. Biochem. 72 (2008) 1962-1964
92. O. Muraoka, Xie Weijia, Tanabe Genzoh, F. A. Amer Mumen, Minematsu Toshie, Yoshikawa Masayuki, On the structure of the bioactive constituent from ayurvedic medicine Salacia reticulata: revision of the literature, Tetrahedron Letters 49 (2008) 7315-7317.
93. K.C. Pramanik, P. Bhattacharya, R. Biswas, D. Bandyopadhyay, M. Mishra, T.K. Chatterjee, Hypoglycemic and antihyperglycemic activity of leaf extract of Pluchea indica Less, Orient Pharm. Exp. Med. 6 (2006) 232-236.
94. I.S. Arsiningtyas, Maria D.P.T. Gunawan-Puteri, Eisuke Kato, Jun Kawabata, Identification of α-glucosidase inhibitors from the leaves of Pluchea indica Less., a traditional Indonesian herb: promotion of natural product use, Nat. Prod. Res. 28 (2014) 1350-1353.
95. J. Chen, S. Mangelinckx, L. Maa, Z. Wang, W. Li, N.D. Kimpe, Caffeoylquinic acid derivatives isolated fromthe aerial parts of Gynura divaricata and their yeast α-glucosidase and PTP1B inhibitory activity, Fitoterapia 99 (2014) 1-6.
96. M. Shibano, D. Tsukamoto, A. Masuda, Y. Tanaka, G. Kusano, Two new pyrrolidine alkaloids, radicamines A and B, as inhibitors of α-glucosidase from Lobelia chinensis Lour, Chem. Pharm. Bull. 49 (2001) 1362-1365.
97. M. Shibano, S. Kitagawa, S. Nakamura, N. Akazawa, G. Kusano, Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb, Chem. Pharm. Bull. (Tokyo) 45 (1997) 700-705.
98. M. Iwu, Handbook of African Medicinal Plants, CRC, Boca Raton, 1993, p. 435.
99. A. Mollataghi, E. Coudiere, H.A. Hadi, M.R. Mukhtar, K. Awang, M. Litaudon, A. Ata, Anti-acetylcholinesterase, anti-α-glucosidase, anti-leishmanial and anti-fungal activities of chemical constituents of Beilschmiedia species, Fitoterapia 83 (2012) 298-302.
100. D. Zhang, M. Fu, S. Gao, J. Li, Curcumin and Diabetes: a Systematic Review, in: Evidence-based Complementary and Alternative Medicine, 2013, p. 16. Article ID 636053, http://dx.doi.org/10.1155/2013/636053.
101. S. Sreejayan, M.N.A. Rao, Curcuminoids as potent inhibitors of lipid peroxidation, J. Pharm. Pharmacol. 46 (1994) 1013-1016.
102. H.S. Lee, KR Pat. 2003090395 (2003).
103. Z. Du, R. Liu, W. Shao, X. Mao, L. Ma, L. Gu, Z. Huang, A.S.C. Chan, α-Glucosidase inhibition of natural curcuminoids and curcumin analogs, Eur. J. Med. Chem. 41 (2006) 213-218.
104. I.E. Mohamed, E.B.E. El Nur, M.I. Choudhary, S.N. Khan, Bioactive natural products from two Sudanese medicinal plants Diospyros mespiliformis and Croton zambesicus, Rec. Nat. Prod. 3 (2009) 198-203
105. Narender, T. et al. Synthesis of novel triterpene and N-allylated/N-alkylated niacin hybrids as α-glucosidase inhibitors. Eur. J. Med. Chem., 63(2013) 162-169.
106. W. Hou, Y. Li, Q. Zhang, X. Wei, A. Peng, L. Chen, Y. Wei, Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors, Phytother. Res. 23 (2009) 614-618.
107. M.S. Akhtar, M.A. Khan, M.T. Malik, Hypoglycaemic activity of Alpinia galanga rhizome and its extracts in rabbits, Fitoterapia 73 (2002) 623-628.
108. A.R. Srividya, S.P. Dhanabal, M.N. Satish kumar, P. Kumar, H. Bavadia, Antioxidant and antidiabetic activity of alpinia galanga, Int. J. Pharmacogn. Phytochemical Res. 3 (2010) 6-12.
109. S. Ghosh, L.L. Rangan, Molecular docking and inhibition Kinetics of αa-glucosidase activity by labdane diterpenes isolated from tora seeds (Alpinia nigra B.L. Burtt.), Appl. Biochem. Biotechnol. 175 (2015) 1477-1489.
110. D. Yang, J. Zhao, S. Liu, F. Songa, Z. Liu, The screening of potential α-glucosidase inhibitors from the polygonum multiflorum extract using ultrafiltration combined with liquid chromatography-tandem mass spectrometry, Anal. Methods 6 (2014) 3353-3359.
111. S.F. Kouam, Shamsun N. Khan, K. Krohn, Bonaventure T. Ngadjui, D.G.W.F. Kapche, D.B. Yapna, S. Zareem, A.M.Y. Moustafa, M.I. Choudhary, α-glucosidase inhibitory anthranols, kenganthranols A-C, from the stem bark of Harungana madagascariensis, J. Nat. Prod. 69 (2006) 229-233.
112. K. Ma, J. Han, L. Bao, T. Wei, H. Liu, Two sarcoviolins with antioxidative and α-glucosidase inhibitory activity from the edible mushroom Sarcodon leucopus collected in Tibet, J. Nat. Prod. 77 (2014) 942-947.
113. H. Kurihara, T. Mitani, J. Kawabata, K. Takahashi, Two new bromophenols from the red alga Odonthalia corymbifera, J. Nat. Prod. 62 (1999) 882-884, 13.
114. H. Kurihara, T. Mitani, J. Kawabata, K. Takahashi, Inhibitory potencies of bromophenols from Rhodomelaceae algae against α-glucosidase activity, Fish. Sci. 65 (1999) 300-303.
115. K.Y. Kim, K.A. Nam, H. Kurihara, S.M. Kim, Potent alpha-glucosidase inhibitors purified from the red alga Grateloupia elliptica, Phytochem 69 (2008) 2820-2825.
116. K.Y. Kim, T.H. Nguyen, H. Kurihara, S.M. Kim, Alpha-glucosidase inhibitory activity of bromophenol purified from the red alga Polyopes lancifolia, J. Food. Sci. 75 (2010) H145-H150.
117. M. Liu, W. Zhang, J. Wei, X. Lin, Synthesis and α-glucosidase inhibitory mechanisms of bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, a potential marine bromophenol α-glucosidase inhibitor, Mar. Drugs 9 (2011) 1554-1565.
118. S.H. Lam, J.M. Chen, C.J. Kang, C.H. Chen, S.S. Lee, Alpha-glucosidase inhibitors from the seeds of Syagrus romanzoffiana, Phytochemistry 69 (2008) 1173-1178.
119. J. Ngoupayo, T.K. Tabopda, M.A. Ali, E. Tsamo, α-Glucosidase inhibitors from Garcinia brevipedicellata (Clusiaceae), Chem. Pharm. Bull. 56 (2008) 1466-1469.
120. X. Bian, X. Fan, C. Ke, Y. Luan, G. Zhao, A. Zeng, Synthesis and α-glucosidase inhibitory activity evaluation of N-substituted aminomethyl-β-D-glucopyranosides, Bioorg. Med. Chem. 21 (2013) 5442-5450.
121. M. Takeuchi, K. Kamata, M. Yoshida, Y. Kameda, K. Matsui, Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal α-glucosidase from rat liver, J. Biochem. 108 (1990) 42-46.
122. N.J. Pawar, V.S. Parihar, S.T. Chavan, R. Joshi, P.V. Joshi, S.G. Sabharwal, V.G. Puranik, D.D. Dhavale, a-Geminal dihydroxymethyl piperidine and pyrrolidine iminosugars: synthesis, conformational analysis, glycosidase inhibitory activity, and molecular docking studies, J. Org. Chem. 77 (2012) 7873-7882.
123. A. Ghavami, B.D. Johnston, B.M. Pinto, A new class of glycosidase inhibitor: synthesis of salacinol and its stereoisomers, J. Org. Chem. 66 (2001) 2312-2317.
124. E.J. Rossi, L. Sim, D.A. Kuntz, D. Hahn, B.D. Johnston, A. Ghavami, M.G. Szczepina, N.S. Kumar, E.E. Sterchi, B. Nichols, B.M. Pinto, D.R. Rose, Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives, FEBS J. 273 (2006) 2673-2683.
125. Y. Natori, T. Imahori, K. Murakami, Y. Yoshimura, S. Nakagawa, A. Kato, I. Adachi, H. Takahata, The synthesis and biological evaluation of 1-C-alkyl-Larabinoiminofuranoses, a novel class of α-glucosidase inhibitors, Bioorg. Med. Chem. Lett. 21 (2011) 738-741.
126. A. Kato, E. Hayashi, S. Miyauchi, I. Adachi, T. Imahori, Y. Natori, Y. Yoshimura, R.J. Nash, H. Shimaoka, I. Nakagome, J. Koseki, S. Hirono, H. Takahata, α-1-C-Butyl-1,4-dideoxy-1,4-imino-L-arabinitol as a second-generation iminosugar-based oral α-glucosidase inhibitor for improving postprandial hyperglycemia, J. Med. Chem. 55 (2012) 10347-10362.
127. Y. Natori, T. Sakuma, Y. Yoshimura, K. Kinami, Y. Hirokami, K. Sato, I. Adachi, A. Kato, H. Takahata, Synthesis and biological evaluation of α-1-C-40-arylbutyl-Larabinoiminofuranoses, a new class of α-glucosidase inhibitors, Bioorg. Med. Chem. Lett. 24 (2014) 3298-3301.
128. S.F. Jenkinson, D. Best, A.W. Saville, J. Mui, et al., C-Branched iminosugars: α-glucosidase inhibition by enantiomers of isoDMDP, isoDGDP, and isoDAB-L-isoDMDP compared to miglitol and miglustat, J. Org. Chem. 78 (2013) 7380-7397.
129. E. Tsou, S. Chen, M. Yang, S. Wang, T.R. Cheng, W. Cheng, Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library, Bioorg. Med. Chem. 16 (2008) 10198-10204.
130. 2, J. Org. Chem. 78 (2013) 7896-7902.
131. S. Mohan, L. Sim, D.R. Rose, B.M. Pinto, Synthesis of S-alkylated sulfoniumions and their glucosidase inhibitory activities against recombinant human maltase glucoamylase, Carbohyd. Res. 342 (2007) 901-912.
132. N. Ardes-Guisot, D.S. Alonzi, G. Reinkensmeier, et al., Selection of the biological activity of DNJ neoglycoconjugates through click. length variation of the side chain, Org. Biomol. Chem. 9 (2011) 5373-5388.
133. A.J. Rawlings, H. Lomas, A.W. Pilling, M.J. Lee, D.S. Alonzi, J.S. Rountree, S.F. Jenkinson, G.W. Fleet, R.A. Dwek, J.H. Jones, T.D. Butters, Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alphaglucosidase inhibitors, ChemBioChem 10 (2009) 1101-1105.
134. R. Eskandari, Kyra Jones, David R. Rose, B. Mario Pinto, Probing the active-site requirements of human intestinal N-terminal maltase glucoamylase: the effect of replacing the sulfate moiety by a methyl ether in ponkoranol, a naturally occurring α-glucosidase inhibitor, Bioorg. Med. Chem. Lett. 20 (2010) 5686-5689.
135. K. Jayakanthan, S. Mohan, B.M. Pinto, Structure proof and synthesis of kotalanol and de-O-sulfonated kotalanol, glycosidase inhibitors isolated from an herbal remedy for the treatment of type-2 diabetes, J. Am. Chem. Soc. 131 (2009) 5621-5626.
136. S. Mohan, K. Jayakanthan, R. Nasi, D.A. Kuntz, D.R. Rose, B.M. Pinto, Synthesis and biological evaluation of heteroanalogues of kotalanol and de-Osulfonated kotalanol, Org. Lett. 12 (2010) 1088-1091.
137. W.D. Seo, J.H. Kim, J.E. Kang, et al., Sulfonamide chalcone as a new class of α-glucosidase inhibitors, Bioorg. Med. Chem. Lett. 15 (2005) 5514-5516.
138. S. Wang, J. Yan, X. Wang, Z. Yang, F. Lin, T. Zhang, Synthesis and evaluation of the α-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives, Eur. J. Med. Chem. 45 (2010) 1250-1255.
139. Y. Wang, T. Zhang, J. Liang, F. Meng, S. Wang, Synthesis and biological evaluation of new substituted 3-[4 (Phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives as α-glucosidase inhibitors, J. Chem. Vol. (2014) 6. Article ID 590129, http://dx.doi.org/10.1155/2014/590129.
140. F.L. Ansari, S. Umbreen, L. Hussain, et al., Syntheses and biological activities of chalcone and 1,5-benzothiazepine derivatives: promising new free-radical scavengers, and esterase, urease, and α-glucosidase inhibitors, Chem. Biodivers. 2 (2005) 487-496.
141. R.R. Rao, A.K. Tiwari, P.P. Reddy, et al., Synthesis of antihyperglycemic, α-glucosidase inhibitory, and DPPH free radical scavenging furanochalcones, Med. Chem. Res. 21 (2012) 760-774.
142. R.G. Damazio, A.P. Zanatta, L.H. Cazarolli, et al., Antihyperglycemic activity of naphthylchalcones, Eur. J. Med. Chem. 45 (2010) 1332-1337.
143. Y. Liu, L. Zou, L. Ma, W. Chen, B. Wang, Z. Xu, Synthesis and pharmacological activities of xanthone derivatives as α-glucosidase inhibitors, Bioorg. Med. Chem. 14 (2006) 5683-5690.
144. Y. Liu, L. Ma, W. Chen, B. Wang, Z. Xu, Synthesis of xanthone derivatives with extended p-systems as α-glucosidase inhibitors: Insight into the probable binding mode, Bioorg. Med. Chem. 15 (2007) 2810-2814.
145. C.M. Park, T. Oie, A.M. Petros, H. Zhang, P.M. Nimmer, R.F. Henry, S.W. Elmore, Design, synthesis, and computational studies of inhibitors of Bcl-XL, J. Am. Chem. Soc. 128 (2006) 16206-16212.
146. J.-G. Ding, J.-H. Shi, D.-F. Cui, L.-F. Xu, S.-H. Duan, L.-H. Guo, J. Fei, Development of peptidic dopamine transporter inhibitors via aromatic modificationmediated conformational restriction, J. Med. Chem. 49 (2006) 4048-4051.
147. P.J. Berti, J.A.B. McCann, Toward a detailed understanding of base excision repair enzymes: transition state and mechanistic analyses of N-glycoside hydrolysis and N-glycoside transfer, Chem. Rev. 106 (2006) 506-555.
148. T. Flatmark, R.C. Stevens, Structural insight into the aromatic amino acid hydroxylases and their disease-related mutant forms, Chem. Rev. 99 (1999) 2137-2160.
149. G. Li, J. He, A. Zhang, Y. Wan, B. Wang, W. Chen, Toward potent α-glucosidase inhibitors based on xanthones: a closer look into the structure-activity correlations, Eur. J. Med. Chem. 46 (2011) 4050-4055.
150. Y. Yutaka, H. Ryoko, Y. Hiroyuki, S. Hiromu, Alpha-glucosidase inhibitory effect of anti-diabetic metal ions and their complexes, Biochimie 91 (2009) 1339-1341.
151. J. Zheng, L. Ma, Silver(I) complexes of 2,4-dihydroxybenzaldehyde-amino acid Schiff bases-Novel noncompetitive α-glucosidase inhibitors, Bioorg. Med. Chem. Lett. 25 (2015) 2156-2161.
152. K. Bharatham, N. Bharatham, K.H. Park, K.W. Lee, Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors, J. Mol. Graph. Model 26 (2008) 1202-1212.
153. M.J. Berridge, R.F. Irvine, Inositol trisphosphate, a novel second messenger in cellular signal transduction, Nature 312 (1984) 315-321.
154. M.J. Berridge, Inositol trisphosphate and calcium signalling, Nature 361 (1993) 315-325.
155. R.F. Irvine, M.J. Schell, Back in the water: the return of the inositol phosphates, Nat. Rev. Mol. Cell Biol. 2 (2001) 327-338.
156. T. Mahapatra, S. Nanda, Asymmetric synthesis of hydroxy-skipped bishomoinositols as potential glycosidase inhibitors, Tetrahedron Asymmetry 21 (2010) 2199-2205.
157. H. Çavdar, O. Talaz, D. Ekinci, Synthesis of novel mono and bis-indole conduritol derivatives and their a/b-glycosidase inhibitory effects, Bioorg. Med. Chem. Lett. 22 (2012) 7499-7503.
158. G. Mehta, S.S. Ramesh, Polycyclitols - novel conduritol and carbasugar hybrids as new glycosidase inhibitors, Can. J. Chem. 83 (2005) 581-594.
159. W. Worawalai, S. Wacharasindhu, P. Phuwapraisirisan, Amine-linked diquercitols as new α-glucosidase inhibitors, Bioorg. Med. Chem. Lett. 24 (2014) 5530-5533
160. E. Rattanangkool, et al., Quercitylcinnamates, a new series of antidiabetic bioconjugates possessing α-glucosidase inhibition and antioxidant, Eur. J. Med. Chem. 66 (2013) 296-304.
161. S.B. Ferreira, A.C.R. Sodero, M.F.C. Cardoso, E.S. Lima, C.R. Kaiser, F.P. Silva Jr., V.F. Ferreira, Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as α-glucosidases inhibitors, J. Med. Chem. 53 (2010) 2364-2375.
162. H. Kashtoh, S. Hussain, A. Khan, S.M. Saad, J.A.J. Khan, K.K. Khan, S. Perveen, M.I. Choudhary, Oxadiazoles and thiadiazoles: novel α-glucosidase inhibitors, Bioorg. Med. Chem. 22 (2014) 5454-5465.
163. M. Taha, N.H. Ismail, S. Lalani, M.Q. Fatmi, et al., Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies, Eur. J. Med. Chem. 92 (2015) 387-400.
164. M. Khan, M. Yousaf, A. Wadood, et al., Discovery of novel oxindole derivatives as potent α-glucosidase inhibitors, Bioorg. Med. Chem. 22 (2014) 3441-3448.
165. J. Eichler, A.W. Lucka, C. Pinilla, R.A. Houghten, Novel α-glucosidase inhibitors identified using multiple cyclic peptide combinatorial libraries, Mol. Divers. 1 (1995) 233-240.
166. Z. Yu, Y. Yin, W. Zhao, Y. Yu, B. Liu, J. Liu, F. Chen, Novel peptides derived from egg white protein inhibiting alpha-glucosidase, Food Chem. 129 (2011) 1376-1382.
167. H.J.J. Kloosterboer, Tibolone: a steroid with a tissue-specific mode of action, Steroid Biochem. Mol. Biol. 76 (2001) 231-238.
168. R.M.E. Vos, S.F.M. Krebbers, C.H.J. Verhoever, L.P.C. Delbressine, The in vivo human metabolism of tibolone, Drug Metab. Dispos 30 (2002) 106-112.
169. S. Steckelbroeck, Y.B. Oyesanmi Jin, H.J. Kloosterboer, T.M. Penning, Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid, Mol. Pharmacol. 66 (2004) 1702-1711.
170. M.J. Reed, H.J. Kloosterboer, Tibolone: a selective tissue estrogenic activity regulator (STEAR), Maturitas 48 (2004) 4-6.
171. Atta-ur-Rahman, M.I. Choudhary, F.Z. Basha, G. Abbas, S.N. Khan, S.A.A. Shah, Science at the interface of chemistry and biology: discoveries of α-glucosidase inhibitors and antiglycation agents, Pure Appl. Chem. 79 (2007) 2263-2268
172. S. Sultan, et al., Fungal transformation of cedryl acetate and α-glucosidase inhibition assay, quantum mechanical calculations and molecular docking studies of its metabolites, Eur. J. Med. Chem. 62 (2013) 764-770.
173. H.W. Xu, G.F. Dai, G.Z. Liu, J.F. Wang, H.M. Liu, Synthesis of andrographolide derivatives: a new family of α-glucosidase inhibitors, Bioorg Med. Chem. 2007 (15) (2007) 4247-4255.
174. H.W. Xu, G. Liu, D. Gui-Fu, C. Wu, H. Liu, Modification of 15-akylidene andrographolide derivatives as alpha-glucosidase inhibitor, Drug Discov. Ther. 1 (2007) 73-77.
175. A. Kato, I. Adachi, M. Miyauchi, K. Ikeda, T. Komae, H. Kizu, Y. Kameda, A.A. Watson, R.J. Nash, M.R. Wormald, Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids from Hyancinthoides non-scripta and Scilla campanulata, Carbohydr. Res. 316 (1999) 95-103.
176. T.D. Heightman, A.T. Vasella, Recent insights into inhibition, structure, and mechanism of configuration-retaining glycosidases, Angew. Chem. 111 (1999) 794-815.
177. A.A. Watson, G.W.J. Fleet, N. Asano, R.J. Molyneux, R.J. Nash, Polyhydroxylated alkaloids - natural occurrence and therapeutic applications, Phytochemistry 56 (2001) 265-295.
178. N. Asano, H. Kuroi, K. Ikeda, H. Kizu, Y. Kameda, A. Kato, I. Adachi, A.A. Watson, R.J. Nash, G.W.J. Fleet, New polyhydroxylated pyrrolizidine alkaloids from Muscari armeniacum: structural determination and biological activity, Tetrahedron Asymmetry 11 (2000) 1-8.
179. 2 stereoisomers, Adv. Synth. Catal. 349 (2007) 1661-1666.
180. J.Y. Kim, J.W. Lee, Y.S. Kim, et al., A novel competitive class of α-glucosidase inhibitors: (E)-1-phenyi-3-(4-styrylphenyi)urea derivatives, ChemBioChem 11 (2010) 2725-2737.
181. 2, a novel α-glucosidase inhibitor, Org. Biomol. Chem. 12 (2014) 2071-2079.